EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics

Ahlam A Ali, Lauren V Cairns, Kathryn M Clarke, Jaine K Blayney, Katrina M Lappin iD, Ken I Mills iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ahlam A Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast BT9 7…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children's Cancer and Leukaemia Group, Children with Cancer and Leukaemia Group.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paediatric acute myeloid leukaemia (AML) continues to present treatment challenges, as no “standard approach” exists to treat those young patients reliably and safely. Combination therapies could become a viable treatment option for treating young patients with AML, allowing multiple pathways to be targeted. Our in silico analysis of AML patients highlighted “cell death and survival” as an aberrant, potentially targetable pathway in paediatric AML patients. Therefore, we aimed to identify novel combination therapies to target apoptosis. Our apoptotic drug screening resulted in the identification of one potential “novel” drug pairing, comprising the Bcl-2 inhibitor ABT-737 combined with the CDK inhibitor Purvalanol-A, as well as one triple combination of ABT-737 + AKT inhibitor + SU9516, which showed significant synergism in a series of paediatric AML cell lines. Using a phosphoproteomic approach to understand the apoptotic mechanism involved, proteins related to apoptotic cell death and cell survival were represented, in agreement with further results showing differentially expressed apoptotic proteins and their phosphorylated forms among combination treatments compared to single-agent treated cells such upregulation of BAX and its phosphorylated form (Thr167), dephosphorylation of BAD (Ser 112), and downregulation of MCL-1 and its phosphorylated form (Ser159/Thr 163). Total levels of Bcl-2 were decreased but correlated with increased levels of phosphorylated Bcl-2, which was consistent with our phosphoproteomic analysis predictions. Bcl-2 phosphorylation was regulated by extracellular-signal-regulated kinase (ERK) but not PP2A phosphatase. Although the mechanism linking to Bcl-2 phosphorylation remains to be determined, our findings provide first-hand insights on potential novel combination treatments for AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteChildHumansCell Line, TumorMyeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2ApoptosisBiphenyl CompoundsNitrophenolsPiperazinesSulfonamides

Stichwörter der Autor:innen

AMLapoptosisdouble combinationdrug screeningpaediatricphosphoproteomicssynergismtriple combination

Substanzen

Myeloid Cell Leukemia Sequence 1 ProteinProto-Oncogene Proteins c-bcl-2ABT-737Biphenyl CompoundsNitrophenolsPiperazinesSulfonamides

Autor:innen und Institutionen

  • Wellcome Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences, Queens University Belfast, Belfast BT9 7AE, Northern Ireland, UK.
  • Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast BT9 7AE, Northern Ireland, UK.
  • Haematology Department, C-Floor Tower Block, Belfast City Hospital, Belfast BT9 7AB, Northern Ireland, UK.

ORCID-Profile: Katrina M Lappin, Ken I Mills

Förderung

  • Children's Cancer and Leukaemia Group
  • Children with Cancer and Leukaemia Group

Zitieren

APA

Ali, A. A., Cairns, L. V., Clarke, K. M., Blayney, J. K., Lappin, K. M., & Mills, K. I. (2023). Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065717

Vancouver

Ali AA, Cairns LV, Clarke KM, Blayney JK, Lappin KM, Mills KI. Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065717

BibTeX
@article{Ali2023,
  author = {Ali, Ahlam A and Cairns, Lauren V and Clarke, Kathryn M and Blayney, Jaine K and Lappin, Katrina M and Mills, Ken I},
  title = {Combination Therapies Targeting Apoptosis in Paediatric AML: Understanding the Molecular Mechanisms of AML Treatments Using Phosphoproteomics},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065717}
}
Kostenlos starten →